<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Magen BioSciences Sold for $14.5M, Codon Devices Closing Doors</title>
	<atom:link href="http://www.xconomy.com/boston/2009/04/03/magen-biosciences-sold-for-145m-codon-devices-closing-doors/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/04/03/magen-biosciences-sold-for-145m-codon-devices-closing-doors/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sun, 22 Nov 2009 19:43:29 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Weekend Edition: News, Money and Drugs for April 4-5, 2009 &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</title>
		<link>http://www.xconomy.com/boston/2009/04/03/magen-biosciences-sold-for-145m-codon-devices-closing-doors/comment-page-1/#comment-52862</link>
		<dc:creator>Weekend Edition: News, Money and Drugs for April 4-5, 2009 &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</dc:creator>
		<pubDate>Sun, 05 Apr 2009 23:52:02 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=19039#comment-52862</guid>
		<description>[...] Dermatology start-up Magen Biosciences sells itself for less than it raised in its first round. The company acquired dermatology assets from Lilly in 2007, but never really did anything. [Xconomy] [...]</description>
		<content:encoded><![CDATA[<p>[...] Dermatology start-up Magen Biosciences sells itself for less than it raised in its first round. The company acquired dermatology assets from Lilly in 2007, but never really did anything. [Xconomy] [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: vcdetractor</title>
		<link>http://www.xconomy.com/boston/2009/04/03/magen-biosciences-sold-for-145m-codon-devices-closing-doors/comment-page-1/#comment-52774</link>
		<dc:creator>vcdetractor</dc:creator>
		<pubDate>Fri, 03 Apr 2009 19:46:50 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=19039#comment-52774</guid>
		<description>Do we need more proof that the VC model is broken?
A 90% failure rate just doesn&#039;t cut it anymore.</description>
		<content:encoded><![CDATA[<p>Do we need more proof that the VC model is broken?<br />
A 90% failure rate just doesn&#8217;t cut it anymore.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
